The role of VLA4 polymorphisms in multiple sclerosis: An association study

Journal of Neuroimmunology

Volumn 189, Issue 1-2, 2007, Pages 125-128

  Andreoli, V ^a   Cittadella, R ^a   Valentino, P ^b   Condino, F ^a   La Russa, A ^a   Liguori, M ^a   Manna, I ^a   Spadafora, P ^a   Nistico R ^b   Pirritano, D ^b   Clodomiro, A ^b   Quattrone, A ^a,b  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

4 integrin; Association study; Genetic susceptibility; Multiple sclerosis; VLA 4 polymorphisms

Indexed keywords

VERY LATE ACTIVATION ANTIGEN 4;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTEGRIN ALPHA4BETA1; ITALY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC;

EID: 34548513311     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.06.015     Document Type: Article

References (15)

1. Berlin C., Bargatze R.F., Campbell J.J., von Andrian U.H., Szabo M.C., Hasslen S.R., Nelson R.D., Berg E.L., Erlandsen S.L., and Butcher E.C. Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80 3 (1995) 413-422 (Feb 10)
2. Carlos T.M., and Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood 84 7 (1994) 2068-2101 (Oct 1)
3. Heymann G.A., Kiesewetter H., and Salama A. Frequencies of a4 A3061G variants and identification of three new variants of the human integrin a4-subunit. Mol. Immunol. 39 14 (2003) 855-860 (May)
4. Hilger-Eversheim K., Moser M., Schorle H., and Buettner R. Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene 260 1-2 (2000) 1-12 (Dec. 30)
5. Kasner P.D., and Hemler M.E. Interchangeable alpha chain cytoplasmic domains play a positive role in control of cell adhesion mediated by VLA-4, a beta 1 integrin. J. Exp. Med. 178 2 (1993) 649-660 (Aug. 1)
6. Keszthelyi E., Karlik S., Hyduk S., Rice G.P., Gordon G., Yednock T., and Horner H. Evidence for a prolonged role of alpha 4 integrin throughout active experimental allergic encephalomyelitis. Neurology 47 4 (1996) 1053-1059 (Oct)
7. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1441-1452
8. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P., Libonati M.A., Willmer-Hulme A.J., Dalton C.M., Miszkiel K.A., and O'Connor P.W. International Natalizumab Multiple Sclerosis Trial Group. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348 1 (2003) 15-23 (Jan 2)
9. Oksenberg J.R., Baranzini S.E., Barcellos F.L., and Hauser S.L. Multiple sclerosis: genomic rewards. J. Neuroimmunol. 113 (2001) 171-184
10. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227-231
11. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85 3 (1996) 299-302 (May 3)
12. Szabo M.C., and McIntyre B.W. Identification of two variants of the human integrin alpha 4 subunit. Mol. Immunol. 32 (1995) 1453-1454
13. von Andrian U.H., and Engelhardt B. Alpha4 integrins as therapeutic targets in autoimmune disease. N. Engl. J. Med. 348 1 (2003) 68-72 (Jan 2)
14. Yauch R.L., Felsenfeld D.P., Kraeft S.K., Chen L.B., Sheetz M.P., and Hemler M.E.. Mutational evidence for control of cell adhesion through integrin diffusion/clustering, independent of ligand binding. J. Exp. Med. 186 8 (1997) 1347-1355 (Oct 20)
15. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., and Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356 6364 (1992) 63-66 (Mar 5)